HUM Humana Inc. Common Stock

NYSE · Health Care · Ver em SEC EDGAR ↗
$389,57
Preço · Ago 18, 2026
Fundamentais a partir de Jul 29, 2026

Sobre Humana Inc. Common Stock Visão geral da empresa da Wikipedia

Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked company based in Kentucky. It is the fourth largest health insurance provider in the U.S.

Ler mais

Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked (by revenues) company based in Kentucky. It is the fourth largest health insurance provider in the U.S.

History

1961–1983: Nursing homes and hospitals

Lawyers David A. Jones Sr. and Wendell Cherry founded a nursing home company in 1961. The company, known in 1968 as Extendicare Inc., became the largest nursing home company in the United States. In 1972, Jones and Cherry sold the nursing home chain to purchase hospitals. Humana became one of the first two for-profit hospital ventures in the U.S. along with Hospital Corporation of America (HCA).

In 1974, the partners changed the corporate name to Humana Inc. The name was meant to change public perception from 'warehousing' or indifferently treating people to providing a higher level of human care and, by extension, more humane care. It grew in the following years, both by business and in 1978 through the takeover of American Medicorp Inc., which doubled the company's size, and grew into the world's largest hospital company in the 1980s. During this period, Humana developed the double corridor model for hospital construction. This design minimized the distance between patients and nurses by placing nursing support services in the interior of the building with patient rooms surrounding the perimeter.

1984–present

As the American health care system changed in the 1980s, "one of its hospitals in Arizona lost a contract with the largest health-maintenance organization in the area [and] Humana created its own health insurance plan."

In 1993, Humana had become the largest hospital operator in the country, owning 77 hospitals. Humana executives spun off hospital operations from health insurance operations to create Galen Health Care. The following year they sold the 73 hospitals of Galen Health Care Inc. to Nashville-based Columbia Hospital Corporation of America for $3.4 billion.

In 1998, one year after Jones had stepped aside as CEO, UnitedHealthcare made an unsuccessful attempt to acquire Humana. Humana pulled out of the acquisition after United stock dropped $2.9 billion in value. In 2001, Humana was a cofounder of Availity.

In 2005, Humana entered into a business partnership with Virgin Group, offering financial incentives to members for healthy behavior, such as regular exercise.

On November 16, 2006, the Centers for Disease Control and Prevention (CDC) and Humana Inc. partnered to expand on traditional private-sector approaches to population health management.

In 2010, Humana bought Texas-based Concentra Inc., which owns urgent-care and physical therapy centers, for $790 million, effectively returning to healthcare services. In May 2011, Humana announced it would be using mobileStorm to transmit protected health information to patients.

In March 2015, Humana announced the sale of Concentra to private equity firm Welsh, Carson, Anderson & Stowe and Select Medical Holdings Corporation for about $1 billion, with proceeds to fund a "$2 billion share buyback program and other corporate spending."

In July 2015, Aetna announced that it would acquire Humana for $37 billion in cash and stock (approximately $230 a share at that time). Aetna and Humana shareholders would own 74% and 26% of the new combined company. However, the U.S. Department of Justice's Antitrust Division alleged the acquisition would be anticompetitive and sued to block the transaction. Following a trial, U.S. district judge John D. Bates of the United States District Court for the District of Columbia agreed and issued an injunction blocking the acquisition. In February 2017, Aetna Inc. and Humana Inc. quashed a $34 billion merger agreement after judges ruled against the merger for a second time.

In July 2018, Humana joined two private equity firms in the acquisition of Kindred Healthcare. The deal provided Humana with a 40% stake in the company's home health, hospice and community care businesses, called "Kindred at Home," for approximately $800 million. In August 2018, Humana announced the creation of a digital health and analytics division called Humana Studio H.

In December 2019, the company announced it would acquire Enclara Healthcare from Consonance Capital Partners and Enclara management.

In 2021, Susan Diamond, formerly occupying an interim position, was announced to be the new permanent CFO. Her appointment to the position comes with the company's focus being turned towards the home healthcare business, acquiring in April of the same year a 60% stake in Kindred at Home, an in-home care and hospice business.

In April 2022, it was announced Humana would sell a 60% interest of its Kindred at Home division to the private investment company, Clayton, Dubilier & Rice, for US$2.8 billion.

In February 2023, Humana announced they were exiting the employer-based commercial group insurance market.

Corporate affairs

Sponsorship

Humana is the presenting sponsor of the Grand Ole Opry and the National Senior Games.

Since 1979, Humana has been a principal sponsor of the annual Humana Festival of New American Plays in Louisville, Kentucky.

Humana was a tour partner of the PGA Tour beginning from 2005 to 2015.

The Humana Distaff Handicap is a Grade 1 race for thoroughbred fillies and mares, four-years-old and up. The race is run each spring on Kentucky Derby day at Churchill Downs and set at a distance of 7 furlongs for a purse of $250,000.

Humana Military Healthcare Services

In 1993, Humana founded Humana Military Healthcare Services (HMHS) as a wholly owned subsidiary. They were awarded their first TRICARE contract in 1995, and began serving military beneficiaries in 1996.

From 2004 to 2009, HMHS was the managed care contractor for the Department of Defense Military Health System TRICARE South Region.

In 2009, HMHS' Managed Care Support Contract was awarded to United Military and Veterans Services, a subsidiary of UnitedHealth Group. HMHS protested that decision and the Government Accountability Office upheld the protest in late 2009.

In 2011, HMHS regained the five-year contract to administer medical benefits to military members and families in the South region, a contract worth $23.5 billion. In 2018, this was moved to the new TRICARE East region during the TRICARE regional realignment.

On December 22, 2022, the Department of Defense announced the award of the managed care support contract for the TRICARE East Region to Humana Military.

Legal campaign against drug price fixing

Humana filed a lawsuit in August 2019, alleging that 37 defendants engaged in a “far-reaching conspiracy” to “blatantly fix the price” of generic drugs. This follows a similar smaller lawsuit from October 2018.

Controversy

In 1987, Humana sued NBC over a story line in the television medical drama St. Elsewhere in which the hospital was to be sold to a for-profit medical corporation and renamed "Ecumena", with subsequent changes to the hospital, both positive and negative, emanating from that change. The company claimed that the program infringed on the Humana trademark. Humana failed to block the airing of the show, but was successful at forcing NBC into showing a disclaimer at the beginning of the September 30 episode saying that the drama had no connection whatsoever with Humana.

On May 30, 1996, Linda Peeno, a physician who was contracted to work for Humana for nine months, testified before Congress as to the downside of managed care. Peeno said she was effectively rewarded by her employer for causing the death of a patient, because it saved the company a half-million dollars. Peeno stated that she felt the "managed care" model was inherently unethical.

In 1999, season one of Michael Moore's TV series The Awful Truth reported on Humana refusing to pay for a diabetic patient with pancreatic failure needing a transplant. The man's policy stated it covered all of his diabetes-related expenses, but another section of the policy stated that it did not cover organ transplants. Moore conducted a fake funeral on the front steps of the Humana building, and three days later Humana changed its policy and authorized the man's treatment.

Michael Moore's 2007 documentary Sicko used the video of Linda Peeno's testimony. On June 28, 2007, Humana declared that Peeno was never a Humana "associate" (permanent, full-time employee), but rather a "part-time contractor." Humana disputed portions of her Congressional testimony by saying that because the patient's healthcare plan did not cover heart transplants, denial of coverage was valid.

On September 21, 2009, the U.S. Dept. of Health and Human Services opened an investigation into Humana for sending flyers to Medicare recipients that the AARP characterized as deceptive. The mail was made to appear to contain official information about Medicare Advantage and prescription drug benefit information, but instead alleged that core Medicare benefits could be cut by the Obama administration's healthcare reform, a claim refuted by John Rother, AARP's executive vice president. Douglas Elmendorf, the head of the Congressional Budget Office (CBO), supported the claim that Medicare benefits could be cut, but his comments were in reference to just one of several congressional bills. CBO estimates of another healthcare reform bill found that changes to premiums would vary. The Centers for Medicare and Medicaid Services instructed Humana to cease all such mailings to Medicare plan members pending an investigation. HHS Secretary Kathleen Sebelius, in a letter to the insurance industry, threatened that bad actors may be excluded from new health insurance markets that were to open in 2014. Senate Republicans pointed out in a letter to Sebelius that a 1997 directive from the Centers for Medicare and Medicaid Services explicitly allowed HMOs to tell members about legislation and urge them to express opinions.

Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗

Wikidata ↗

HUM Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas

Preço
$389.57
Capitalização de Mercado
$77.42B
P/E (TTM)
39.6
EPS (TTM)
$9.84
Receita (TTM)
$129.66B
Rendimento div.
0.55%
ROE
7.0%
Dívida/Capital
0.7
Intervalo 52 Semanas
$163 – $429

HUM Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização

Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS

Receita e Lucro Líquido $129.66B
10-point trend, +138.4%
2016-12-31 2025-12-31
EPS $9.84
10-point trend, +141.8%
2016-12-31 2025-12-31
Fluxo de caixa livre $375M
10-point trend, -73.4%
2016-12-31 2025-12-31
Margens 0.92%

Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?

Métrica
Tendência de 5 anos
HUM
Mediana de Pares
P/E (TTM)
5-point trend, +27.2%
39.6
36.8
P/S (TTM)
4-point trend, -64.2%
0.6
0.8
P/B
4-point trend, -56.6%
4.4
3.4
EV / EBITDA
4-point trend, -33.7%
25.8
Price / FCF (Preço / FCF)
4-point trend, +362.5%
206.4

Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC

Métrica
Tendência de 5 anos
HUM
Mediana de Pares
Operating Margin (Margem Operacional)
5-point trend, -44.9%
2.1%
Net Profit Margin (Margem de Lucro Líquido)
5-point trend, -73.9%
0.92%
0.85%
ROA
5-point trend, -66.3%
2.5%
2.8%
ROE
5-point trend, -61.5%
7.0%
8.2%
ROIC
5-point trend, -26.6%
7.4%

Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial

Métrica
Tendência de 5 anos
HUM
Mediana de Pares
Debt / Equity (Dívida / Patrimônio Líquido)
5-point trend, +7.0%
0.7
Current Ratio (Índice de liquidez corrente)
5-point trend, +23.3%
2.0
1.5
Quick Ratio (Índice de Liquidez Seca)
5-point trend, +18.1%
1.4

Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos

Métrica
Tendência de 5 anos
HUM
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
5-point trend, +56.1%
10.1%
Revenue CAGR 3Y (CAGR Receita 3A)
5-point trend, +56.1%
11.8%
Revenue CAGR 5Y (CAGR Receita 5A)
5-point trend, +56.1%
10.9%
EPS YoY
5-point trend, -56.6%
-1.4%
Net Income YoY (Lucro Líquido Ano a Ano)
5-point trend, -59.5%
-1.6%

Métricas por Ação EPS, valor patrimonial por ação, fluxo de caixa por ação, dividendo por ação

Métrica
Tendência de 5 anos
HUM
Mediana de Pares
EPS (Diluted) (EPS (Diluído))
5-point trend, -56.6%
$9.84

Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber

Métrica
Tendência de 5 anos
HUM
Mediana de Pares
Payout Ratio (Índice de Pagamento)
5-point trend, +199.9%
36.2%

Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos

Dividend Yield
0.55%
Índice de Pagamento
36.2%
CAGR Dividendos 5 anos
Data exValor
26 de Junho de 2026$0,8850
27 de Março de 2026$0,8850
26 de Dezembro de 2025$0,8850
26 de Setembro de 2025$0,8850
27 de Junho de 2025$0,8850
28 de Março de 2025$0,8850
31 de Dezembro de 2024$0,8850
30 de Setembro de 2024$0,8850
28 de Junho de 2024$0,8850
27 de Março de 2024$0,8850
28 de Dezembro de 2023$0,8850
28 de Setembro de 2023$0,8850
29 de Junho de 2023$0,8850
30 de Março de 2023$0,8850
29 de Dezembro de 2022$0,7880
29 de Setembro de 2022$0,7880
29 de Junho de 2022$0,7880
30 de Março de 2022$0,7880
30 de Dezembro de 2021$0,7000
29 de Setembro de 2021$0,7000

HUM Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta

COMPRA 33 analistas
  • Compra forte 8 24,2%
  • Compra 8 24,2%
  • Manter 15 45,5%
  • Venda 2 6,1%
  • Venda forte 0 0,0%

Preço-alvo de 12 meses

23 analistas · 2026-08-19
Alvo mediano $415.00 +6,5%
Alvo médio $416.43 +6,9%

Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados

Surpresa Média
0.42%
Período EPS Actual EPS est. Surpresa
30 de Junho de 2026 $7.61 $7.29 0.32%
31 de Março de 2026 $10.31 $10.29 0.02%
31 de Dezembro de 2025 $-3.96 $-4.05 0.09%
30 de Setembro de 2025 $3.24 $2.85 0.39%
30 de Junho de 2025 $6.27 $5.98 0.29%
31 de Março de 2025 $11.58 $10.17 1.4%

Comparação de pares (subindústria GICS) Métricas chave vs pares do setor

Ticker Capitalização de Mercado P/E Receita YoY Margem Líquida ROE Margem Bruta
HUM $50.90B 26.0 10.1% 0.92% 7.0%
UNH $299.08B 25.0 11.8% 2.7% 12.0%
ELV $77.37B 13.9 12.5% 2.8% 13.3%
CNC $20.24B -3.0 19.4% -3.4% -28.8% 7.3%
MOH $8.85B 19.5 11.8% 1.0% 10.9%
HQY $7.12B 34.0 9.5% 16.4% 10.1% 69.5%
ALHC $4.03B 46.1% -0.02% -0.52%
CLOV -5.1 40.3% -4.5% -26.2%
PGNY $2.14B 39.5 10.4% 4.5% 11.3% 23.6%

Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa

Demonstração de Resultados 13
Dados anuais de Demonstração de Resultados para HUM
Métrica Tendência 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +167.3% $129.66B $117.76B $106.37B $92.87B $83.06B $77.16B $64.89B $56.91B $53.77B $54.38B $54.29B $48.50B
SG&A Expense 12-point trend, +102.3% $15.45B $13.70B $13.19B $12.67B $10.12B $10.05B $7.38B $7.53B $6.57B $7.17B $7.29B $7.64B
Operating Income 12-point trend, +14.5% $2.70B $2.56B $4.01B $3.80B $3.15B $4.99B $3.19B $3.10B $4.26B $1.74B $2.35B $2.36B
Interest Expense 10-point trend, +156.8% · · $493M $401M $326M $283M $242M $218M $242M $189M $186M $192M
Other Non-op 10-point trend, -451000000.00 $-451M $-181M $-137M $-68M $532M $-103M $506M $-33M $0 $0 · ·
Pretax Income 12-point trend, -33.7% $1.44B $1.62B $3.33B $3.57B $3.42B $4.67B $3.47B $2.07B $4.02B $1.55B $2.43B $2.17B
Income Tax 12-point trend, -75.6% $250M $413M $836M $762M $485M $1.31B $763M $391M $1.57B $938M $1.16B $1.02B
Net Income 12-point trend, +3.6% $1.19B $1.21B $2.49B $2.81B $2.93B $3.37B $2.71B $1.68B $2.45B $614M $1.28B $1.15B
EPS (Basic) 12-point trend, +32.7% $9.87 $10.01 $20.09 $22.20 $22.79 $25.47 $20.20 $12.24 $16.94 $4.11 $8.54 $7.44
EPS (Diluted) 12-point trend, +33.7% $9.84 $9.98 $20.00 $22.08 $22.67 $25.31 $20.10 $12.16 $16.81 $4.07 $8.44 $7.36
Shares (Basic) 12-point trend, -21.9% 120,454,000 120,571,000 123,866,000 126,419,000 128,688,000 132,199,000 134,055,000 137,486,000 144,493,000 149,375,000 149,455,000 154,187,000
Shares (Diluted) 12-point trend, -22.5% 120,826,000 120,869,000 124,441,000 127,094,000 129,396,000 133,012,000 134,727,000 138,403,000 145,585,000 150,917,000 151,142,000 155,874,000
EBITDA 12-point trend, +14.5% $2.70B $2.56B $4.01B $3.80B $3.15B $4.99B $3.19B $3.10B $4.26B $1.74B $2.35B $2.36B
Balanço Patrimonial 26
Dados anuais de Balanço Patrimonial para HUM
Métrica Tendência 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +117.1% $4.20B $2.22B $4.69B $5.06B $3.39B $4.67B $4.05B $2.34B $4.04B $3.88B $2.57B $1.94B
Short-term Investments 7-point trend, +43.1% $15.70B $18.21B $16.63B $13.88B $13.19B $12.55B $10.97B · · · · ·
Receivables 12-point trend, +210.5% $3.27B $2.70B $2.04B $1.67B $1.81B $1.14B $1.06B $1.01B $854M $1.28B $1.16B $1.05B
Other Current Assets 12-point trend, +138.6% $9.56B $6.68B $6.63B $5.57B $6.49B $5.28B $3.81B $3.56B $2.95B $3.44B $4.71B $4.01B
Current Assets 12-point trend, +110.7% $32.73B $29.82B $29.99B $26.18B $24.89B $23.64B $19.89B $16.95B $17.40B $16.19B $15.71B $15.54B
PP&E (Net) 12-point trend, +81.7% $2.23B $2.53B $3.03B $3.22B $3.07B $2.37B $1.96B $1.74B $1.58B $1.50B $1.38B $1.23B
PP&E (Gross) 12-point trend, +89.9% $5.52B $5.67B $5.88B $6.36B $5.95B $5.49B $4.62B $4.05B $3.56B $3.19B $2.72B $2.91B
Accum. Depreciation 12-point trend, +95.8% $3.29B $3.14B $2.85B $3.14B $2.87B $3.12B $2.66B $2.31B $1.98B $1.69B $1.34B $1.68B
Goodwill 12-point trend, +199.8% $9.69B $9.63B $9.55B $9.14B $11.09B $4.45B $3.93B $3.90B $3.28B $3.27B $3.27B $3.23B
Intangibles 12-point trend, +156.4% $1.13B $1.44B $1.69B $1.76B $2.64B $329M $177M $245M $226M $280M $357M $440M
Other Non-current Assets 12-point trend, +97.6% $3.13B $3.38B $3.38B $3.38B $4.38B $2.13B $1.83B $1.38B $2.17B $2.23B $2.48B $1.58B
Total Assets 12-point trend, +107.9% $48.91B $46.48B $47.06B $43.05B $44.36B $34.97B $29.07B $25.41B $27.18B $25.40B $24.68B $23.53B
Accounts Payable 12-point trend, +172.9% $5.72B $5.26B $6.57B $5.24B $4.51B $4.01B $3.75B $3.07B $4.07B $2.47B $2.21B $2.10B
Short-term Debt 5-point trend, +1694000000.00 · · · · · · · $1.69B $150M $300M $299M $0
Current Liabilities 12-point trend, +118.8% $16.35B $16.94B $18.87B $17.18B $15.33B $13.39B $10.93B $10.08B $9.41B $7.82B $8.15B $7.47B
Capital Leases 7-point trend, +25.9% $418M $392M $444M $456M $546M $355M $332M · · · · ·
Other Non-current Liabilities 12-point trend, +941.1% $2.46B $1.95B $1.66B $1.47B $2.38B $1.79B $1.14B $581M $237M $263M $235M $236M
Total Liabilities 12-point trend, +124.6% $31.17B $30.03B $30.75B $27.68B $28.25B $21.24B $17.04B $15.25B $17.34B $14.71B $14.33B $13.88B
Total Debt 12-point trend, +223.4% $12.37B $11.14B $10.21B $9.03B $10.54B $6.06B $4.97B $6.07B $4.92B $4.09B $4.12B $3.83B
Common Stock Flat — no change across 12 periods $33M $33M $33M $33M $33M $33M $33M $33M $33M $33M $33M $33M
Retained Earnings 12-point trend, +193.2% $29.07B $28.32B $27.54B $25.49B $23.09B $20.52B $17.48B $15.07B $13.67B $11.45B $11.02B $9.92B
Treasury Stock 12-point trend, +404.8% $14.42B $14.37B $13.66B $12.16B $10.16B $9.92B $8.46B $7.32B $6.33B $3.30B $3.29B $2.86B
AOCI 12-point trend, -383.9% $-633M $-1.07B $-999M $-1.30B $42M $391M $156M $-159M $19M $-66M $58M $223M
Stockholders' Equity 12-point trend, +83.0% $17.66B $16.38B $16.26B $15.31B $16.08B $13.73B $12.04B $10.16B $9.84B $10.69B $10.35B $9.65B
Liabilities + Equity 12-point trend, +107.9% $48.91B $46.48B $47.06B $43.05B $44.36B $34.97B $29.07B $25.41B $27.18B $25.40B $24.68B $23.53B
Shares Outstanding 7-point trend, +0.0% 198,719,000 198,719,000 198,690,000 198,667,000 198,649,000 198,649,000 198,630,000 · · · · ·
Fluxo de Caixa 17
Dados anuais de Fluxo de Caixa para HUM
Métrica Tendência 202520242023202220212020201920182017201620152014
D&A 10-point trend, +112.8% $698M $839M $779M $709M $596M · · $444M $410M $388M $354M $328M
Stock-based Comp 12-point trend, +145.9% $241M $207M $175M $216M $180M $181M $163M $137M $157M $115M $109M $98M
Deferred Tax 12-point trend, +217.2% $75M $-192M $-164M $-100M $15M $195M $162M $194M $132M $-71M $-2M $-64M
Amort. of Intangibles 12-point trend, -57.9% $51M $60M $67M $81M $65M $88M $70M $90M $75M $77M $93M $121M
Restructuring 2-point trend, -68.2% · · · · · · $47M · $148M · · ·
Operating Cash Flow 12-point trend, -43.1% $921M $2.97B $3.98B $4.59B $2.26B $5.64B $5.28B $2.17B $4.05B $1.94B $868M $1.62B
CapEx 12-point trend, +3.4% $546M $575M $1.00B $1.14B $1.34B $964M $736M $612M $524M $527M $523M $528M
Investing Cash Flow 12-point trend, +3707.9% $2.27B $-2.95B $-3.49B $-1.01B $-6.56B $-3.06B $-1.28B $-3.09B $-2.94B $-1.36B $320M $-63M
Net Debt Issued 6-point trend, +20.0% · · · · · · $-400M $0 $-800M $0 $0 $-500M
Stock Repurchased 12-point trend, -82.7% $151M $817M $1.57B $2.10B $79M $1.82B $1.07B $1.09B $3.37B $104M $385M $872M
Net Stock Activity 12-point trend, +82.7% $-151M $-817M $-1.57B $-2.10B $-79M $-1.82B $-1.07B $-1.09B $-3.37B $-104M $-385M $-872M
Dividends Paid 12-point trend, +150.0% $430M $431M $431M $392M $354M $323M $291M $265M $220M $177M $172M $172M
Financing Cash Flow 12-point trend, -60.3% $-1.22B $-2.49B $-856M $-1.91B $3.02B $-1.96B $-2.29B $-785M $-945M $732M $-552M $-758M
Net Change in Cash 12-point trend, +148.3% $1.98B $-2.47B $-367M $1.67B $-1.28B $619M $1.71B $-1.70B $165M $1.31B $636M $797M
Taxes Paid 11-point trend, -44.7% · $570M $997M $758M $227M $1.13B $518M $631M $1.50B $916M $1.18B $1.03B
Free Cash Flow 12-point trend, -65.6% $375M $2.39B $2.98B $3.47B $946M $4.67B $4.55B $1.56B $3.52B $1.41B $345M $1.09B
Levered FCF 10-point trend, +163.8% · · $2.61B $3.15B $666M $4.47B $4.36B $1.38B $3.38B $1.33B $247M $989M
Lucratividade 7
Dados anuais de Lucratividade para HUM
Métrica Tendência 202520242023202220212020201920182017201620152014
Operating Margin 12-point trend, -57.1% 2.1% 2.2% 3.8% 4.1% 3.8% 6.5% 4.9% 5.5% 7.9% 3.2% 4.3% 4.9%
Net Margin 12-point trend, -61.0% 0.92% 1.0% 2.3% 3.0% 3.5% 4.4% 4.2% 3.0% 4.5% 1.1% 2.4% 2.4%
Pretax Margin 12-point trend, -75.2% 1.1% 1.5% 3.1% 3.8% 4.1% 6.1% 5.3% 3.6% 7.5% 2.9% 4.5% 4.5%
EBITDA Margin 12-point trend, -57.1% 2.1% 2.2% 3.8% 4.1% 3.8% 6.5% 4.9% 5.5% 7.9% 3.2% 4.3% 4.9%
ROA 12-point trend, -52.0% 2.5% 2.6% 5.5% 6.4% 7.4% 10.5% 9.9% 6.4% 9.3% 2.5% 5.3% 5.2%
ROE 12-point trend, -42.3% 7.0% 7.4% 15.8% 18.2% 18.1% 22.8% 22.9% 16.2% 23.3% 5.8% 12.8% 12.1%
ROIC 12-point trend, -19.7% 7.4% 7.1% 11.3% 12.3% 10.1% 18.1% 14.6% 15.5% 17.6% 4.7% 8.5% 9.3%
Liquidez e Solvência 5
Dados anuais de Liquidez e Solvência para HUM
Métrica Tendência 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, +0.1% 2.0 1.8 1.6 1.5 1.6 1.8 1.8 1.7 1.9 2.1 1.9 2.0
Quick Ratio 12-point trend, +236.0% 1.4 1.4 1.2 1.2 1.2 1.4 0.5 0.3 0.5 0.7 0.5 0.4
Debt / Equity 12-point trend, +76.7% 0.7 0.7 0.6 0.6 0.7 0.4 0.4 0.6 0.5 0.4 0.4 0.4
LT Debt / Equity 12-point trend, +76.7% 0.7 0.7 0.6 0.6 0.7 0.4 0.4 0.4 0.5 0.4 0.4 0.4
Interest Coverage 10-point trend, -33.8% · · 8.1 9.5 9.7 17.6 13.2 14.2 17.6 9.2 12.6 12.3
Eficiência 2
Dados anuais de Eficiência para HUM
Métrica Tendência 202520242023202220212020201920182017201620152014
Asset Turnover 12-point trend, +23.9% 2.7 2.5 2.4 2.1 2.1 2.4 2.4 2.2 2.0 2.2 2.3 2.2
Receivables Turnover 12-point trend, -5.2% 43.4 49.7 57.4 53.3 56.3 70.3 62.7 60.9 50.4 44.6 49.0 45.8
Por Ação 7
Dados anuais de Por Ação para HUM
Métrica Tendência 202520242023202220212020201920182017201620152014
Book Value / Share 4-point trend, +15.3% $88.85 $82.40 $81.85 $77.07 · · · · · · · ·
Revenue / Share 12-point trend, +244.9% $1073.15 $974.29 $854.81 $730.72 $641.94 $580.06 $481.63 $411.20 $369.32 $360.32 $359.19 $311.15
Cash Flow / Share 12-point trend, -26.6% $7.62 $24.54 $31.99 $36.09 $17.48 $42.39 $39.22 $15.70 $27.83 $12.83 $5.74 $10.38
Cash / Share 4-point trend, -17.0% $21.14 $11.18 $23.62 $25.47 · · · · · · · ·
Dividend / Share 3-point trend, +4.5% · · · · · · · · · $1 $1 $1
Dividend Paid / Share 12-point trend, +221.8% $4 $4 $3 $3 $3 $2 $2 $2 $1 $1 $1 $1
EPS (TTM) 12-point trend, +33.7% $9.84 $9.98 $20.00 $22.08 $22.67 $25.31 $20.10 $12.16 $16.81 $4.07 $8.44 $7.36
Taxas de Crescimento 10
Dados anuais de Taxas de Crescimento para HUM
Métrica Tendência 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, +32.0% 10.1% 10.7% 14.5% 11.8% 7.7% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +4.2% 11.8% 12.3% 11.3% · · · · · · · · ·
Revenue CAGR 5Y 10.9% · · · · · · · · · · ·
EPS YoY 5-point trend, +86.6% -1.4% -50.1% -9.4% -2.6% -10.4% · · · · · · ·
EPS CAGR 3Y 3-point trend, -212.8% -23.6% -23.9% -7.5% · · · · · · · · ·
EPS CAGR 5Y -17.2% · · · · · · · · · · ·
Net Income YoY 5-point trend, +87.8% -1.6% -51.5% -11.3% -4.3% -12.9% · · · · · · ·
Net Income CAGR 3Y 3-point trend, -160.0% -24.9% -25.6% -9.6% · · · · · · · · ·
Net Income CAGR 5Y -18.8% · · · · · · · · · · ·
Dividend CAGR 5Y 5.9% · · · · · · · · · · ·
Avaliação (TTM) 17
Dados anuais de Avaliação (TTM) para HUM
Métrica Tendência 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +167.3% $129.66B $117.76B $106.37B $92.87B $83.06B $77.16B $64.89B $56.91B $53.77B $54.38B $54.29B $48.50B
Net Income TTM 12-point trend, +3.6% $1.19B $1.21B $2.49B $2.81B $2.93B $3.37B $2.71B $1.68B $2.45B $614M $1.28B $1.15B
Market Cap 4-point trend, -50.0% $50.90B $50.42B $90.96B $101.76B · · · · · · · ·
Enterprise Value 4-point trend, -52.8% $43.36B $41.13B $79.86B $91.85B · · · · · · · ·
P/E 12-point trend, +33.4% 26.0 25.4 22.9 23.2 20.5 16.2 18.2 23.6 14.8 50.1 21.2 19.5
P/S 4-point trend, -64.2% 0.4 0.4 0.9 1.1 · · · · · · · ·
P/B 4-point trend, -56.6% 2.9 3.1 5.6 6.6 · · · · · · · ·
P / Tangible Book 4-point trend, -67.8% 7.4 9.5 18.1 23.1 · · · · · · · ·
P / Cash Flow 4-point trend, +149.1% 55.3 17.0 22.8 22.2 · · · · · · · ·
P / FCF 4-point trend, +362.5% 135.7 21.1 30.6 29.3 · · · · · · · ·
EV / EBITDA 4-point trend, -33.7% 16.0 16.1 19.9 24.2 · · · · · · · ·
EV / FCF 4-point trend, +336.5% 115.6 17.2 26.8 26.5 · · · · · · · ·
EV / Revenue 4-point trend, -66.2% 0.3 0.3 0.8 1.0 · · · · · · · ·
Dividend Yield 4-point trend, +115.4% 0.84% 0.85% 0.47% 0.39% · · · · · · · ·
Earnings Yield 12-point trend, -25.0% 3.8% 3.9% 4.4% 4.3% 4.9% 6.2% 5.5% 4.2% 6.8% 2.0% 4.7% 5.1%
Payout Ratio 12-point trend, +141.3% 36.2% 35.7% 17.3% 14.0% 12.1% 9.6% 10.8% 15.8% 9.0% 28.8% 13.5% 15.0%
Annual Payout 12-point trend, +150.0% $430M $431M $431M $392M $354M $323M $291M $265M $220M $177M $172M $172M

Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos

Demonstração de Resultados
2025-12-312024-12-312023-12-312022-12-312021-12-31
Receita $129.66B$117.76B$106.37B$92.87B$83.06B
Margem Operacional % 2.1%2.2%3.8%4.1%3.8%
Lucro líquido $1.19B$1.21B$2.49B$2.81B$2.93B
EPS Diluído $9.84$9.98$20.00$22.08$22.67
Balanço Patrimonial
2025-12-312024-12-312023-12-312022-12-312021-12-31
Dívida / Patrimônio Líquido 0.70.70.60.60.7
Índice de liquidez corrente 2.01.81.61.51.6
Índice de Liquidez Seca 1.41.41.21.21.2
Fluxo de Caixa
2025-12-312024-12-312023-12-312022-12-312021-12-31
Fluxo de caixa livre $375M$2.39B$2.98B$3.47B$946M

Últimas notícias Notícias recentes mencionando esta empresa

Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos

📊

Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.

Sua seleção é salva e acompanha você em todos os tickers.

Investidores institucionais (13F) 1.050 declarantes · $33.7B total · Em 30 de Junho de 2026

Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.

Atividade institucional — Q2 2026 vs trimestre anterior
Novas posições Posições encerradas Aumentou Diminuído Variação líquida de ações
255 (+143 vs trimestre anterior) 81 (-80 vs trimestre anterior) 313 (+42 vs trimestre anterior) 273 (-45 vs trimestre anterior) +23.7M

Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.

Instituição Valor Ações % de 13F rastreado Tipo
Dodge & Cox $4.345.737.744 10.940.380 12,90% Ações
VANGUARD CAPITAL MANAGEMENT LLC $3.115.642.737 7.843.620 9,25% Ações
VANGUARD PORTFOLIO MANAGEMENT LLC $2.311.405.702 5.818.956 6,86% Ações
STATE STREET CORP $2.172.441.313 5.457.072 6,45% Ações
EAGLE CAPITAL MANAGEMENT LLC $1.528.010.749 3.846.762 4,54% Ações
Sessa Capital IM, L.P. $1.480.732.883 3.727.740 4,40% Ações
GEODE CAPITAL MANAGEMENT, LLC $1.181.074.714 2.976.242 3,51% Ações
Capital International Investors $950.462.637 2.392.826 2,82% Ações
NAYA CAPITAL MANAGEMENT UK LTD $728.407.339 1.833.763 2,16% Ações
NORGES BANK $694.505.009 1.748.414 2,06% Ações
GOLDMAN SACHS GROUP INC $659.096.868 1.659.274 1,96% Ações
FMR LLC $615.633.048 1.549.854 1,83% Ações
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $544.502.820 1.370.784 1,62% Ações
Capital Research Global Investors $443.462.035 1.116.990 1,32% Ações
Slate Path Capital LP $428.969.795 1.079.930 1,27% Ações
Capital World Investors $406.119.738 1.022.425 1,21% Ações
Newport Trust Company, LLC $384.768.345 968.653 1,14% Ações
CITADEL ADVISORS LLC $363.376.856 914.800 1,08% Opção de compra
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $348.908.912 878.377 1,04% Ações
DIMENSIONAL FUND ADVISORS LP $331.490.508 834.526 0,98% Ações
BARROW HANLEY MEWHINNEY & STRAUSS LLC $314.921.577 792.814 0,93% Ações
CITADEL ADVISORS LLC $310.904.094 782.700 0,92% Opção de venda
WELLINGTON MANAGEMENT GROUP LLP $282.117.958 710.231 0,84% Ações
VANGUARD FIDUCIARY TRUST CO $267.791.027 674.163 0,79% Ações
Maple Rock Capital Partners Inc. $249.553.862 628.251 0,74% Ações
Diamond Hill Capital Management, LLC (Investment Advisor) $245.555.446 618.185 0,73% Ações
GOLDMAN SACHS GROUP INC $232.333.978 584.900 0,69% Opção de compra
MARSHALL WACE, LLP $216.873.381 545.978 0,64% Ações
CITADEL ADVISORS LLC $178.080.082 448.316 0,53% Ações
High Ground Investment Management LLP $177.941.848 447.968 0,53% Ações
1832 Asset Management L.P. $176.401.430 444.090 0,52% Ações
BCV Asset Management Inc. $173.695.656 445.719 0,52% Ações
BANK OF AMERICA CORP /DE/ $172.703.708 434.781 0,51% Ações
Holocene Advisors, LP $165.040.541 415.489 0,49% Ações
BNP PARIBAS FINANCIAL MARKETS $147.490.964 371.308 0,44% Ações
MILLENNIUM MANAGEMENT LLC $140.098.700 352.698 0,42% Ações
JANE STREET GROUP, LLC $137.080.622 345.100 0,41% Opção de compra
Swiss National Bank $134.522.525 338.660 0,40% Ações
JANE STREET GROUP, LLC $122.542.370 308.500 0,36% Opção de venda
STEADFAST CAPITAL MANAGEMENT LP $122.423.204 308.200 0,36% Ações
BlackRock, Inc. $120.890.332 304.341 0,36% Ações
Mitsubishi UFJ Asset Management Co., Ltd. $115.565.201 290.935 0,34% Ações
VANGUARD ASSET MANAGEMENT, Ltd $109.135.401 274.748 0,32% Ações
AMERIPRISE FINANCIAL INC $108.302.217 272.614 0,32% Ações
Legal & General Group Plc $103.424.967 260.372 0,31% Ações
Vanguard Global Advisers, LLC $103.330.825 260.135 0,31% Ações
GOLDMAN SACHS GROUP INC $103.078.590 259.500 0,31% Opção de venda
NEUBERGER BERMAN GROUP LLC $102.585.352 258.258 0,30% Ações
BANK OF NOVA SCOTIA $102.313.941 257.575 0,30% Ações
RHUMBLINE ADVISERS $102.294.748 257.527 0,30% Ações
Sumitomo Mitsui Trust Group, Inc. $101.464.685 255.437 0,30% Ações
GLENVIEW CAPITAL MANAGEMENT, LLC $100.979.680 254.216 0,30% Ações
Gotham Asset Management, LLC $89.318.889 224.860 0,27% Ações
Balyasny Asset Management L.P. $87.965.958 221.454 0,26% Ações
FIRST TRUST ADVISORS LP $85.094.587 214.226 0,25% Ações
Ensign Peak Advisors, Inc $83.532.585 210.293 0,25% Ações
ADAGE CAPITAL PARTNERS GP, L.L.C. $83.463.866 210.120 0,25% Ações
Brandywine Global Investment Management, LLC $80.388.706 313.859 0,24% Ações
California Public Employees Retirement System $80.274.587 202.091 0,24% Ações
WOLVERINE TRADING, LLC $76.135.109 298.300 0,23% Opção de compra
Camber Capital Management LP $73.344.000 300.000 0,22% Ações
National Pension Service $70.860.473 178.391 0,21% Ações
BARCLAYS PLC $70.472.788 177.415 0,21% Ações
Susquehanna Portfolio Strategies, LLC $69.949.250 176.097 0,21% Ações
Walleye Trading LLC $69.473.778 174.900 0,21% Opção de compra
CANADA PENSION PLAN INVESTMENT BOARD $68.018.761 171.237 0,20% Ações
ARGA Investment Management, LP $66.165.730 166.572 0,20% Ações
ORBIMED ADVISORS LLC $65.183.802 164.100 0,19% Ações
Solel Partners LP $64.742.888 162.990 0,19% Ações
AMF Tjanstepension AB $61.961.951 155.989 0,18% Ações
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $60.794.124 153.049 0,18% Ações
Perpetual Ltd $57.945.659 145.878 0,17% Ações
CI INVESTMENTS INC. $57.302.560 144.259 0,17% Ações
AMERICAN CENTURY COMPANIES INC $56.575.256 142.426 0,17% Ações
Squarepoint Ops LLC $56.047.742 141.100 0,17% Opção de venda
Aberdeen Group plc $53.345.852 134.298 0,16% Ações
WOLVERINE TRADING, LLC $52.653.949 206.300 0,16% Opção de venda
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $52.178.000 131.358 0,15% Ações
ING GROEP NV $51.583.784 129.862 0,15% Ações
Squarepoint Ops LLC $50.685.272 127.600 0,15% Opção de compra
Walleye Trading LLC $49.573.056 124.800 0,15% Opção de venda
D. E. Shaw & Co., Inc. $46.514.462 117.100 0,14% Opção de compra
BRAIDWELL LP $45.481.690 114.500 0,14% Ações
Jain Global LLC $43.694.200 110.000 0,13% Opção de venda
BANK OF MONTREAL /CAN/ $43.207.208 108.774 0,13% Ações
Zurcher Kantonalbank (Zurich Cantonalbank) $42.190.325 106.214 0,13% Ações
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $42.127.167 106.055 0,13% Ações
AVIVA PLC $41.509.093 104.499 0,12% Ações
VIRGINIA RETIREMENT SYSTEMS ET Al $41.468.472 161.904 0,12% Ações
ROYAL BANK OF CANADA $41.033.000 103.301 0,12% Ações
Pentwater Capital Management LP $39.722.000 100.000 0,12% Opção de compra
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $39.284.661 98.899 0,12% Ações
Point72 Asset Management, L.P. $39.122.595 98.491 0,12% Ações
PFM Health Sciences, LP $37.487.638 94.375 0,11% Ações
Summit Street Capital Management, LLC $36.325.372 91.449 0,11% Ações
Columbus Hill Capital Management, L.P. $35.501.935 89.376 0,11% Ações
Korea Investment CORP $34.579.193 87.053 0,10% Ações
Quantinno Capital Management LP $32.817.091 82.616 0,10% Ações
Fisher Funds Management LTD $32.811.563 82.603 0,10% Ações
Swedbank AB $32.034.603 80.647 0,10% Ações

Executivos da empresa 76 insiders · 46 diretores · 27 conselheiros

Investidor com informação privilegiada Função Última atividade Ações detidas Compras 12m Vendas 12m Líquido 12m
James A. Rechtin President & CEO 14 de Maio de 2025 P 30.474 0 0 $0
Bruce D Broussard Chief Executive Officer 21 de Fevereiro de 2024 A 110.130 0 0 $0
Celeste Mellet Chief Financial Officer 24 de Fevereiro de 2025 A 29.676 0 0 $0
Susan M Diamond Chief Financial Officer 31 de Dezembro de 2024 J 20.165 0 0 $0
Brian A Kane Chief Financial Officer 22 de Fevereiro de 2021 A 24.342 0 0 $0
Steven E Mcculley Interim CFO & Treasurer 9 de Maio de 2014 G 14.916 0 0 $0
George Renaudin II President, Insurance 27 de Março de 2025 J 15.702 0 0 $0
David Dintenfass President, Enterprise Growth 24 de Fevereiro de 2025 A 16.234 0 0 $0
Sanjay K Shetty President, CenterWell 24 de Fevereiro de 2025 A 11.566 0 0 $0
M.D. Andrew C. Agwunobi, Seg. President, Home Solutions 24 de Fevereiro de 2023 A 182 0 0 $0
Timothy Alan Wheatley Segment President, Retail 15 de Dezembro de 2022 M 3.983 0 0 $0
Joseph William Jasser Seg. President, Care Delivery 15 de Dezembro de 2017 M 222 0 0 $0
Thomas J Liston President - Retail Segment 18 de Fevereiro de 2014 A 105.443 0 0 $0
James E Murray EVP & COO 31 de Março de 2017 J 34.668 0 0 $0
Japan Mehta Chief Information Officer 24 de Fevereiro de 2025 A 8.628 0 0 $0
John-Paul W. Felter SVP, Chief Accting Off & Cont. 24 de Fevereiro de 2025 A 1.767 0 0 $0
Michelle A. O'Hara Chief Human Resources Officer 24 de Fevereiro de 2025 A 11.266 0 0 $0
Joseph C Ventura Chief Legal Officer 24 de Fevereiro de 2025 A 17.267 0 0 $0
Vishal Agrawal Chief Strat & Corp Dev Officer 24 de Fevereiro de 2025 A 16.717 0 0 $0
Timothy S. Huval Chief Administrative Officer 31 de Dezembro de 2024 G 7.111 0 0 $0
Samir Deshpande Chief Information Officer 15 de Dezembro de 2024 M 14.015 0 0 $0
William Kevin Fleming Chief Corporate Aff. Officer 21 de Fevereiro de 2024 A 11.723 0 0 $0
Susan D. Schick Seg Pres. Grp. & Military Bus. 24 de Fevereiro de 2023 F 3.687 0 0 $0
William H Shrank Chief Medical Officer 1 de Maio de 2022 M 4.294 0 0 $0
Cynthia H Zipperle SVP, Chief Acct Officer & Cont 22 de Março de 2022 J 5.723 0 0 $0
Heather Cox Chief Dig Health & Analyt Off. 25 de Fevereiro de 2022 F 6.014 0 0 $0
Christopher H. Hunter Seg Pres. Gr. & Military Bus. 16 de Março de 2021 G 8.168 0 0 $0
Elizabeth D Bierbower Strategic Advisor 18 de Dezembro de 2019 M 18.092 0 0 $0
Brian P. Leclaire Strategic Advisor 15 de Dezembro de 2019 M 6.339 0 0 $0
Jody L Bilney Chief Consumer Officer 25 de Fevereiro de 2019 A 9.774 0 0 $0
Roy A Beveridge, Chief Medical Officer 19 de Fevereiro de 2019 M 10.791 0 0 $0
Todoroff M Christopher Chief Legal Officer 15 de Dezembro de 2018 M 11.136 0 0 $0
Heidi S Margulis Chief Corp. Affairs Officer 15 de Dezembro de 2018 M 6.476 0 0 $0
Christopher E Kay SVP & Chief Innovation Officer 17 de Março de 2017 M 4.361 0 0 $0
Tim S Mcclain Group Pres, Govt & Other Busin 18 de Fevereiro de 2014 A 1.101 0 0 $0
Bruce D Perkins Sgmt Pres, Healthcare Services 18 de Fevereiro de 2014 A 15.946 0 0 $0
Paul B. K. Kusserow Sr VP & Ch Strat Dev Officer 24 de Junho de 2013 M 19.347 0 0 $0
HATHCOCK BONNIE C Sr VP & Chief Human Res. Off 24 de Dezembro de 2012 G 2.287 0 0 $0
Venkata R Madabhushi SVP & Chief Innov & Mrkting Of 28 de Abril de 2012 F 11.946 0 0 $0
GOODMAN BRUCE J Sr. VP 23 de Fevereiro de 2012 A 23.280 0 0 $0
Jonathan T Lord MD Sr VP & Chief Innovation Off. 4 de Fevereiro de 2009 I 0 0 0 $0
Arthur P Hipwell Senior Vice President 27 de Março de 2008 J 302 0 0 $0
Kathleen Pellegrino VP and Acting General Counsel 25 de Fevereiro de 2008 F 13.836 0 0 $0
Steven O Moya Sr. VP-Chief Marketing Officer 31 de Dezembro de 2007 I 0 0 0 $0
John M Bertko Vice President & Chief Actuary 23 de Fevereiro de 2007 M 57.548 0 0 $0
Eugene R Shields Senior Vice President-Gov Prgm 6 de Janeiro de 2005 M 0 0 0 $0
Kurt J Hilzinger Conselheiro 30 de Junho de 2026 A 19.448 0 0 $0
Frank A Damelio Conselheiro 2 de Janeiro de 2026 A 20.634 0 0 $0
Karen Katz Conselheiro 31 de Dezembro de 2025 A 590 0 0 $0
David T Feinberg Conselheiro 30 de Junho de 2025 A 441 0 0 $0

Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto

Ativistas e proprietários de 5%+ 1 participação

Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.

Declarante Declarado Participação Status Propósito Declaração
David A. Jones ×2 declarações 12 de Novembro de 2003 Declaração inicial SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Participação em ETFs Detido por 200 ETFs

O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.

Fundo Peso Unidades Em Fonte
IHF · iShares Trust 4,29% 144.763 SH 8 de Agosto de 2026 Diário
FXH · First Trust Exchange-Traded AlphaDE… 2,95% 109.132 NS 30 de Abril de 2026 N-PORT
SMRI · EA Series Trust 2,54% 58.016 NS 30 de Abril de 2026 N-PORT
RPV · Invesco Exchange-Traded Fund Trust 2,27% 100.446 SH 8 de Agosto de 2026 Diário
TGLB · T. Rowe Price Exchange-Traded Funds… 2,26% 2.111 NS 30 de Abril de 2026 N-PORT
PTH · Invesco Exchange-Traded Fund Trust 1,80% 11.546 SH 8 de Agosto de 2026 Diário
SRHQ · Elevation Series Trust 1,63% 13.322 NS 30 de Abril de 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1,60% 32.564 SH 8 de Agosto de 2026 Diário
CVAR · ETF Opportunities Trust 1,51% 2.473 NS 30 de Abril de 2026 N-PORT
EPMV · Harbor ETF Trust 1,20% 225 NS 30 de Abril de 2026 N-PORT
ABCS · EA Series Trust 1,19% 441 NS 29 de Maio de 2026 N-PORT
MFSV · MFS Active Exchange Traded Funds Tr… 1,14% 17.702 NS 31 de Maio de 2026 N-PORT
NUMV · Nushares ETF Trust 0,96% 17.434 NS 30 de Abril de 2026 N-PORT
FTA · First Trust Exchange-Traded AlphaDE… 0,95% 52.223 NS 30 de Abril de 2026 N-PORT
VOE · VANGUARD INDEX FUNDS 0,82% 771.237 SH 8 de Agosto de 2026 Diário
ITAN · EA Series Trust 0,77% 2.259 NS 29 de Maio de 2026 N-PORT
CGMM · Capital Group Equity ETF Trust I 0,72% 65.925 NS 31 de Maio de 2026 N-PORT
IYH · iShares Trust 0,72% 71.884 SH 8 de Agosto de 2026 Diário
RWL · Invesco Exchange-Traded Fund Trust … 0,71% 183.164 SH 8 de Agosto de 2026 Diário
VHT · VANGUARD WORLD FUND 0,70% 360.880 SH 8 de Agosto de 2026 Diário
AUSF · Global X Funds 0,70% 19.401 NS 31 de Maio de 2026 N-PORT
AVIE · AMERICAN CENTURY ETF TRUST 0,63% 211 NS 31 de Maio de 2026 N-PORT
FVAL · FIDELITY COVINGTON TRUST 0,59% 30.459 NS 30 de Abril de 2026 N-PORT
IXJ · iShares Trust 0,56% 62.953 SH 8 de Agosto de 2026 Diário
RXL · ProShares Trust 0,53% 1.258 NS 31 de Maio de 2026 N-PORT
FAB · First Trust Exchange-Traded AlphaDE… 0,47% 2.755 NS 30 de Abril de 2026 N-PORT
VO · VANGUARD INDEX FUNDS 0,46% 2.601.869 SH 8 de Agosto de 2026 Diário
FHLC · FIDELITY COVINGTON TRUST 0,46% 55.439 NS 30 de Abril de 2026 N-PORT
FEX · First Trust Exchange-Traded AlphaDE… 0,45% 28.340 NS 30 de Abril de 2026 N-PORT
DEUS · DBX ETF Trust 0,43% 3.849 NS 29 de Maio de 2026 N-PORT
IWS · iShares Trust 0,42% 181.221 SH 8 de Agosto de 2026 Diário
CURE · Direxion Shares ETF Trust 0,41% 2.404 NS 30 de Abril de 2026 N-PORT
SPXD · DBX ETF Trust 0,37% 81 NS 31 de Maio de 2026 N-PORT
IMCV · iShares Trust 0,36% 11.394 SH 8 de Agosto de 2026 Diário
QARP · DBX ETF Trust 0,36% 887 NS 29 de Maio de 2026 N-PORT
VRP · Invesco Exchange-Traded Fund Trust … 0,35% 10.520.000 8 de Agosto de 2026 Diário
PRF · Invesco Exchange-Traded Fund Trust 0,35% 90.057 SH 8 de Agosto de 2026 Diário
AVMC · AMERICAN CENTURY ETF TRUST 0,34% 4.484 NS 31 de Maio de 2026 N-PORT
GMOV · GMO ETF Trust 0,34% 1.004 NS 31 de Maio de 2026 N-PORT
FNDX · SCHWAB STRATEGIC TRUST 0,32% 265.500 NS 31 de Maio de 2026 N-PORT
IUS · Invesco Exchange-Traded Self-Indexe… 0,32% 7.839 SH 8 de Agosto de 2026 Diário
IWR · iShares Trust 0,32% 489.015 SH 8 de Agosto de 2026 Diário
IMCB · iShares Trust 0,30% 13.840 SH 8 de Agosto de 2026 Diário
FNDB · SCHWAB STRATEGIC TRUST 0,29% 12.439 NS 31 de Maio de 2026 N-PORT
PALC · Pacer Funds Trust 0,29% 2.779 NS 30 de Abril de 2026 N-PORT
SPVU · Invesco Exchange-Traded Fund Trust … 0,28% 1.250 NS 31 de Maio de 2026 N-PORT
PFIG · Invesco Exchange-Traded Fund Trust … 0,28% 320.000 8 de Agosto de 2026 Diário
BRCE · MFS Active Exchange Traded Funds Tr… 0,27% 299 NS 31 de Maio de 2026 N-PORT
FFLC · FIDELITY COVINGTON TRUST 0,26% 12.272 NS 30 de Abril de 2026 N-PORT
VLUE · iShares Trust 0,24% 62.558 SH 8 de Agosto de 2026 Diário